Anticipating Problems During First Wave of COVID-19 Vaccinations
January 14th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.
Planning, Implementing Walgreens’ COVID-19 Vaccination Program at Long-term Care Facilities
January 13th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.
The Enforcement of 340B Drug Pricing Laws May Change Under the Biden Administration
January 8th 2021Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a letter that was signed by President-elect Biden’s pick for HHS secretary to the outgoing HHS secretary on the enforcement of 340B drug pricing laws.
Short Videos Can Be Effective for Improving Medication Adherence
January 8th 2021Patrick Campbell, PharmD, PhD, the senior director of research at the Pharmacy Quality Alliance, discusses why sending a short video to a patient’s phone can improve primary medication adherence and why it’s more effective than text messages.
Government’s Unwillingness to Act on 340B Drug Pricing Affects Patients at the Pharmacy Counter
January 7th 2021Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on how pharmacies and their patients are affected by issues regarding the regulation of the sale of 340B discounted drugs.
A Case of Pregnancy Despite Infertility From Congenital Plasminogen Deficiency
January 6th 2021Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the details of a patient who had a successful pregnancy despite documented infertility due to congenital plasminogen deficiency.
Resources to Help Pharmacists Develop Alternative Flu Vaccination Sites
January 5th 2021Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.